Reposted
PPolpharma@polpharma
Polpharma S.A. (Starogard Gdański, Polska). 2024 revenue ~PLN3.5Mld. Largest Polish pharma. Cardiology, gastroenterology, CNS. Apo-Cardio, Polocard. API manufacturing. 7.5K employees.
8:29:09 PM · Jul 9, 2026
Polpharma S.A. (Starogard Gdański, Polska). 2024 revenue ~PLN3.5Mld. Largest Polish pharma. Cardiology, gastroenterology, CNS. Apo-Cardio, Polocard. API manufacturing. 7.5K employees.
The selectivity for para-substitution was >15:1 under optimized conditions.
The hydrogenation selectivity improved dramatically with the modified ligand.